Pancreatic-β-cell-specifying transcription factor Nkx6.1, indispensable for embryonic development of the pancreatic epithelium and commitment to β-cell lineage, directly controls the expression of a glucose transporter (Glut2), pyruvate carboxylase (Pcx), and genes for insulin processing (endoplasmic reticulum oxidoreductase-1β, Ero1lb; zinc transporter-8, Slc30a8). The Nkx6.1 decline in aging diabetic Goto-Kakizaki rats contributes to β-cell trans-differentiation into δ-cells. Elucidating further Nkx6.1 roles, we studied Nkx6.1 ablation in rat INS-1E cells, prepared by CRISPR/Cas9 gene editing from single colonies. INS-1ENkx6.1-/- cells exhibited unchanged glucose-stimulated insulin secretion (GSIS), moderately decreased phosphorylating/non-phosphorylating respiration ratios at high glucose; unchanged but delayed ATP-elevation responses to glucose; delayed uptake of fluorescent glucose analog, but slightly improved cytosolic Ca2+-oscillations, induced by glucose; despite approximately halved Glut2, Pcx, Ero1lb, and Slc30a8 expression, and reduced nuclear receptors Nr4a1 and Nr4a3. Thus, ATP synthesis was time-compensated, despite the delayed GLUT2-mediated glucose uptake and crippled pyruvate-malate redox shuttle (owing to the PCX-deficiency) in INS-1ENkx6.1-/- cells. Nkx6.1 thus controls the expression of genes that are not essential for acute insulin secretion, the function of which can be compensated for. Considerations that Nkx6.1 deficiency is an ultimate determinant of β-cell pathology beyond cell trans-(de-)differentiation or β-cell identity are not supported by our results.

Department of Mitochondrial Physiology No 75 Institute of Physiology of the Czech Academy of Sciences Vídeňská 1083 Prague 14220 Czech Republic

Zobrazit více v PubMed

Moin ASM, Butler AE. Alterations in beta cell identity in type 1 and type 2 diabetes. Curr. Diab. Rep. 2019;19:83. doi: 10.1007/s11892-019-1194-6. PubMed DOI PMC

Hunter CS, Stein RW. Evidence for loss in identity, de-differentiation, and trans-differentiation of islet β-cells in type 2 diabetes. Front. Genet. 2017;8:35. doi: 10.3389/fgene.2017.00035. PubMed DOI PMC

Lawlor N, Stitzel ML. (Epi)genomic heterogeneity of pancreatic islet function and failure in type 2 diabetes. Mol. Metab. 2019;27S:S15–S24. doi: 10.1016/j.molmet.2019.06.002. PubMed DOI PMC

Zhu Y, Liu Q, Zhou Z, Ikeda Y. PDX1, Neurogenin-3, and MAFA: Critical transcription regulators for beta cell development and regeneration. Stem Cell Res. Ther. 2017;8:240. doi: 10.1186/s13287-017-0694-z. PubMed DOI PMC

Wang YJ, Kaestner KH. Single-cell RNA-Seq of the pancreatic islets—a promise not yet fulfilled? Cell Metab. 2019;29:539–544. doi: 10.1016/j.cmet.2018.11.016. PubMed DOI PMC

Ibarra Urizar A, et al. Beta-cell dysfunction induced by non-cytotoxic concentrations of Interleukin-1β is associated with changes in expression of beta-cell maturity genes and associated histone modifications. Mol. Cell Endocrinol. 2019;496:110524. doi: 10.1016/j.mce.2019.110524. PubMed DOI

Christensen AA, Gannon M. The beta cell in type 2 diabetes. Curr. Diab. Rep. 2019;19:81. doi: 10.1007/s11892-019-1196-4. PubMed DOI

De Jesus DF, Kulkarni RN. "Omics" and "epi-omics" underlying the β-cell adaptation to insulin resistance. Mol. Metab. 2019;27S:S42–S48. doi: 10.1016/j.molmet.2019.06.003. PubMed DOI PMC

Nasteska D, Viloria K, Everett L, Hodson DJ. Informing β-cell regeneration strategies using studies of heterogeneity. Mol. Metab. 2019;27S:S49–S59. doi: 10.1016/j.molmet.2019.06.004. PubMed DOI PMC

Dominguez-Gutierrez G, Xin Y, Gromada J. Heterogeneity of human pancreatic β-cells. Mol Metab. 2019;27S:S7–S14. doi: 10.1016/j.molmet.2019.06.015. PubMed DOI PMC

Aigha II, Abdelalim EM. NKX6.1 transcription factor: A crucial regulator of pancreatic β cell development, identity, and proliferation. Stem Cell Res. Ther. 2020;11:459. doi: 10.1186/s13287-020-01977-0. PubMed DOI PMC

Al-Khawaga S, et al. Pathways governing development of stem cell-derived pancreatic beta cells: Lessons from embryogenesis. Biol. Rev. Camb. Philos. Soc. 2018;93:364–389. doi: 10.1111/brv.12349. PubMed DOI

Inoue H, et al. Isolation, characterization, and chromosomal mapping of the human Nkx6.1 gene (NKX6A), a new pancreatic islet homeobox gene. Genomics. 1997;40:367–370. doi: 10.1006/geno.1996.4568. PubMed DOI

Villasenor A, Chong DC, Cleaver O. Biphasic Ngn3 expression in the developing pancreas. Dev. Dyn. 2008;237:3270–3279. doi: 10.1002/dvdy.21740. PubMed DOI PMC

Bader E, et al. Identification of proliferative and mature beta-cells in the islets of Langerhans. Nature. 2016;535:430–434. doi: 10.1038/nature18624. PubMed DOI

Johnston NR, et al. Beta cell hubs dictate pancreatic islet responses to glucose. Cell Metab. 2016;24:389–401. doi: 10.1016/j.cmet.2016.06.020. PubMed DOI PMC

Schaffer AE, et al. Nkx6.1 controls a gene regulatory network required for establishing and maintaining pancreatic Beta cell identity. PLoS Genet. 2013;9:e1003274. doi: 10.1371/journal.pgen.1003274. PubMed DOI PMC

Taylor BL, Liu FF, Sander M. Nkx6.1 is essential for maintaining the functional state of pancreatic beta cells. Cell Rep. 2013;4:1262–1275. doi: 10.1016/j.celrep.2013.08.010. PubMed DOI PMC

Schisler JC, et al. The Nkx6.1 homeodomain transcription factor suppresses glucagon expression and regulates glucose-stimulated insulin secretion in islet beta cells. Proc. Natl. Acad. Sci. USA. 2005;102:7297–7302. doi: 10.1073/pnas.0502168102. PubMed DOI PMC

Donelan W, et al. Distinct regulation of hepatic nuclear factor 1alpha by NKX6.1 in pancreatic beta cells. J. Biol. Chem. 2010;285:12181–12189. doi: 10.1074/jbc.M109.064238. PubMed DOI PMC

Alán L, et al. Delta cell hyperplasia in adult Goto-Kakizaki (GK/MolTac) diabetic rats. J. Diabetes Res. 2015;2015:385395–385416. doi: 10.1155/2015/385395. PubMed DOI PMC

Špaček T, et al. Nkx6.1 decline accompanies mitochondrial DNA reduction but subtle nucleoid size decrease in pancreatic islet β-cells of diabetic Goto Kakizaki rats. Sci. Rep. 2017;7:15674. doi: 10.1038/s41598-017-15958-6. PubMed DOI PMC

Gauthier BR, et al. The beta-cell specific transcription factor Nkx6.1 inhibits glucagon gene transcription by interfering with Pax6. Biochem. J. 2007;403:593–601. doi: 10.1042/BJ20070053. PubMed DOI PMC

Sander M, et al. Homeobox gene Nkx6.1 lies downstream of Nkx2.2 in the major pathway of beta-cell formation in the pancreas. Development. 2000;127:5533–5540. doi: 10.1242/dev.127.24.5533. PubMed DOI

Taylor BL, Benthuysen J, Sander M. Postnatal beta-cell proliferation and mass expansion is dependent on the transcription factor Nkx6.1. Diabetes. 2015;64:897–903. doi: 10.2337/db14-0684. PubMed DOI PMC

Plecitá-Hlavatá L, et al. Glucose-stimulated insulin secretion fundamentally requires H2O2 signaling by NADPH oxidase 4. Diabetes. 2020;69:1341–1354. doi: 10.2337/db19-1130. PubMed DOI

Plecitá-Hlavatá L, et al. Mitochondrial superoxide production decreases on glucose-stimulated insulin secretion in pancreatic β cells due to decreasing mitochondrial matrix NADH/NAD + ratio. Antioxid. Redox Signal. 2020;33:789–815. doi: 10.1089/ars.2019.7800. PubMed DOI PMC

Ježek P, Holendová B, Jabůrek M, Dlasková A, Plecitá-Hlavatá L. Contribution of mitochondria to insulin secretion by various secretagogues. Antioxid. Redox Signal. 2022;36:920–952. doi: 10.1089/ars.2021.0113. PubMed DOI PMC

Ježek P, Holendová B, Jabůrek M, Tauber J, Dlasková A, Plecitá-Hlavatá L. The pancreatic β-Cell: The perfect redox system. Antioxidants. 2021;10:197. doi: 10.3390/antiox10020197. PubMed DOI PMC

Ježek P, Jabůrek M, Plecitá-Hlavatá L. Contribution of oxidative stress and impaired biogenesis of pancreatic β-cells to type 2 diabetes. Antioxid. Redox Signal. 2019;31:722–751. doi: 10.1089/ars.2018.7656. PubMed DOI PMC

Leguina-Ruzzi AA, et al. Glucose-induced expression of DAPIT in pancreatic β-cells. Biomolecules. 2020;10:1026. doi: 10.3390/biom10071026. PubMed DOI PMC

Rorsman P, Ascroft FM. Pancreatic β-cell electrical activity and insulin secretion: Of mice and men. Physiol. Rev. 2018;98:117–214. doi: 10.1152/physrev.00008.2017. PubMed DOI PMC

Kaestner KH, et al. What is a β cell?—Chapter I in the Human Islet Research Network (HIRN) review series. Mol. Metab. 2021;53:101323. doi: 10.1016/j.molmet.2021.101323. PubMed DOI PMC

Guo S, et al. Inactivation of specific beta cell transcription factors in type 2 diabetes. J. Clin. Investig. 2013;123:3305–3316. doi: 10.1172/JCI65390. PubMed DOI PMC

Gao T, et al. Pdx1 maintains beta cell identity and function by repressing an alpha cell program. Cell Metab. 2014;19:259–271. doi: 10.1016/j.cmet.2013.12.002. PubMed DOI PMC

Jennings RE, et al. Development of the human pancreas from foregut to endocrine commitment. Diabetes. 2013;62:3514–3522. doi: 10.2337/db12-1479. PubMed DOI PMC

Dorrell C, et al. Human islets contain four distinct subtypes of beta cells. Nat. Commun. 2016;7:11756. doi: 10.1038/ncomms11756. PubMed DOI PMC

Xin Y, et al. RNA sequencing of single human islet cells reveals type 2 diabetes genes. Cell Metab. 2016;24:608–615. doi: 10.1016/j.cmet.2016.08.018. PubMed DOI

Tritschler S, Theis FJ, Lickert H, Bottcher A. Systematic singlecell analysis provides new insights into heterogeneity and plasticity of the pancreas. Mol. Metab. 2017;6:974–990. doi: 10.1016/j.molmet.2017.06.021. PubMed DOI PMC

Lawlor N, et al. Single-cell transcriptomes identify human islet cell signatures and reveal cell-type-specific expression changes in type 2 diabetes. Genome Res. 2017;27:208–222. doi: 10.1101/gr.212720.116. PubMed DOI PMC

Segerstolpe A, et al. Single-cell transcriptome profiling of human pancreatic islets in health and type 2 diabetes. Cell Metab. 2016;24:593–607. doi: 10.1016/j.cmet.2016.08.020. PubMed DOI PMC

Muraro MJ, et al. A single-cell transcriptome atlas of the human pancreas. Cell Syst. 2016;3:385–394. doi: 10.1016/j.cels.2016.09.002. PubMed DOI PMC

Zhang J, McKenna LB, Bogue CW, Kaestner KH. The diabetes gene Hhex maintains δ-cell differentiation and islet function. Genes Dev. 2014;28:829–834. doi: 10.1101/gad.235499.113. PubMed DOI PMC

Cinti F, et al. Evidence of beta-cell dedifferentiation in human type 2 diabetes. J. Clin. Endocrinol. Metab. 2016;101:1044–1054. doi: 10.1210/jc.2015-2860. PubMed DOI PMC

Butler AE, et al. Beta-cell deficit in obese type 2 diabetes, a minor role of beta-cell dedifferentiation and degranulation. J. Clin. Endocrinol. Metab. 2016;101:523–532. doi: 10.1210/jc.2015-3566. PubMed DOI PMC

Md Moin AS, Dhawan S, Cory M, Butler PC, Rizza RA, Butler AE. Increased frequency of hormone negative and polyhormonal endocrine cells in lean individuals with type 2 diabetes. J. Clin. Endocrinol. Metab. 2016;101:3628–3636. doi: 10.1210/jc.2016-2496. PubMed DOI PMC

Butler AE, Campbell-Thompson M, Gurlo T, Dawson DW, Atkinson M, Butler PC. Marked expansion of exocrine and endocrine pancreas with incretin therapy in humans with increased exocrine pancreas dysplasia and the potential for glucagonproducing neuroendocrine tumors. Diabetes. 2013;62:2595–2604. doi: 10.2337/db12-1686. PubMed DOI PMC

Liu T, et al. Increased frequency of beta cells with abnormal NKX6.1 expression in type 2 diabetes but not in subjects with higher risk for type 2 diabetes. BMC Endocr. Disord. 2021;21:47. doi: 10.1186/s12902-021-00708-7. PubMed DOI PMC

Nakai J, Ohkura M, Imoto K. A high signal-to-noise Ca2+ probe composed of a single green fluorescent protein. Nat. Biotechnol. 2001;19:137–141. doi: 10.1038/84397. PubMed DOI

Chen TW, et al. Ultrasensitive fluorescent proteins for imaging neuronal activity. Nature. 2013;499:295–300. doi: 10.1038/nature12354. PubMed DOI PMC

Mitochondria to plasma membrane redox signaling is essential for fatty acid β-oxidation-driven insulin secretion

Pitfalls of Mitochondrial Redox Signaling Research